Variability in drug metabolism: importance of genetic constitution
- 1 April 1987
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 9 (2), 85-90
- https://doi.org/10.1007/bf01960741
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Debrisoquine polymorphism and the metabolism and action of metoprolol, timolol, propranolol and atenololXenobiotica, 1986
- The molecular mechanisms of two common polymorphisms of drug oxidation-evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidationXenobiotica, 1986
- The genetic polymorphism of sparteine metabolismXenobiotica, 1986
- Characterization of a common genetic defect of cytochrome P-450 function (debrisoquine-sparteine type polymorphism) — Increased michaelis constant (km) and loss of stereoselectivity of bufuralol 1′-hydroxylation in poor metabolizersBiochemical and Biophysical Research Communications, 1984
- Debrisoquine-type polymorphism of drug oxidation: purification from human liver of a cytochrome P450 isozyme with high activity for bufuralol hydroxylationFEBS Letters, 1984
- Impairment of Phenytoin Parahydroxylation as a Cause of Severe IntoxicationTherapeutic Drug Monitoring, 1983
- Ethnic Differences in Drug MetabolismClinical Pharmacokinetics, 1982
- Defective Oxidation of DrugsClinical Pharmacokinetics, 1982
- Understanding the Dose-Effect RelationshipClinical Pharmacokinetics, 1981
- Disease and Acetylation PolymorphismClinical Pharmacokinetics, 1977